Manulife (Manufacturers Life Insurance)
CCCC icon

Manulife (Manufacturers Life Insurance)’s C4 Therapeutics CCCC Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Buy
+27,513
New +$94.1K ﹤0.01% 2690
2025
Q2 		– Sell
-22,021
Closed -$35.2K – 2919
2025
Q1 		$35.2K Buy
22,021
+448
+2% +$1.34K ﹤0.01% 2859
2024
Q4 		$77.7K Sell
21,573
-20,091
-48% -$99.9K ﹤0.01% 2875
2024
Q3 		$237K Buy
41,664
+18,746
+82% +$113K ﹤0.01% 2590
2024
Q2 		$106K Sell
22,918
-49,300
-68% -$294K ﹤0.01% 2808
2024
Q1 		$590K Buy
72,218
+45,889
+174% +$356K ﹤0.01% 2133
2023
Q4 		$149K Buy
+26,329
New +$60K ﹤0.01% 2718
2023
Q3 		– Sell
-65,195
Closed -$179K – 2981
2023
Q2 		$179K Sell
65,195
-16,556
-20% -$53.2K ﹤0.01% 2656
2023
Q1 		$257K Hold
81,751
– – ﹤0.01% 2405
2022
Q4 		$473K Sell
81,751
-36
-0% -$298 ﹤0.01% 2031
2022
Q3 		$702K Sell
81,787
-6,902
-8% -$71.7K ﹤0.01% 1773
2022
Q2 		$655K Buy
88,689
+3,723
+4% +$32.8K ﹤0.01% 1866
2022
Q1 		$2.05M Buy
84,966
+65,224
+330% +$1.58M ﹤0.01% 1494
2021
Q4 		$646K Buy
19,742
+352
+2% +$13.9K ﹤0.01% 2096
2021
Q3 		$866K Buy
19,390
+308
+2% +$13.2K ﹤0.01% 1931
2021
Q2 		$722K Buy
19,082
+12,964
+212% +$464K ﹤0.01% 2182
2021
Q1 		$226K Sell
6,118
-62
-1% -$2.47K ﹤0.01% 2819
2020
Q4 		$205K Buy
+6,180
New +$179K ﹤0.01% 2758

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CCCC Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 27,513 shares worth $128K. The stake represents ﹤0.01% of the portfolio and ranks #2690 among its holdings. This is a return to the name: Manulife (Manufacturers Life Insurance) previously reported a position in CCCC as recently as Q1 2025.

Manulife (Manufacturers Life Insurance) first reported a position in CCCC in Q4 2020 and has held it in 18 quarters since. The position peaked at $2.05M in Q1 2022. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 27,513 shares of C4 Therapeutics worth $128K as of Q2 2026.
  • C4 Therapeutics was a new Manulife (Manufacturers Life Insurance) position in Q2 2026.
  • C4 Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2690 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in C4 Therapeutics in Q4 2020 and has held it in 18 quarters since.
  • Manulife (Manufacturers Life Insurance)'s C4 Therapeutics position peaked at $2.05M in Q1 2022.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.